Recommendation

Recommended In Favor

Conditional recommendation

WHO suggests paclitaxel or pegylated liposomal doxorubicin for pharmacological treatment for people living with HIV with Kaposi’s sarcoma.
Year
2025
Institution
World health organization
Guideline
Not available